About Dr. Aditya Sarin
Dr. Aditya Sarin is a distinguished and dynamic Medical Oncologist, recently honoured as the ‘Young Oncologist of the Year 2024′. With advanced training in Immuno-Oncology, Cancer Genomics, and Precision Oncology from Harvard Medical School, he represents the new frontier of cancer treatment. Dr. Sarin is ESMO board-certified and brings a modern, evidence-based approach to patient care. He specialises in creating highly personalised treatment plans using the latest modalities like chemotherapy, targeted therapy, and immunotherapy. Renowned for his unwavering commitment and empathetic nature, Dr. Aditya Sarin is a medical oncologist in India and deeply respected for understanding the holistic needs of his patients, ensuring they receive the most advanced and compassionate care available.
- MBBS: Swami Rama Himalayan University, Dehradun (2007 - 2013)
- MD (Internal Medicine): Swami Rama Himalayan University, Dehradun (2013 - 2016)
- DrNB (Medical Oncology): BLK-Max Super Speciality Hospital, New Delhi (2018 - 2021)
- Immuno-Oncology, Cancer Genomics and Precision Oncology: Harvard Medical School, Boston, USA
- ESMO Preceptorship in Multidisciplinary Care and Future Perspectives in Breast Cancer Management: European Society for Medical Oncology (ESMO)
- ESMO Preceptorship in Multidisciplinary Care and Future Perspectives in Urothelial Cancer: European Society for Medical Oncology (ESMO)
- ESMO Board Certified: European Society for Medical Oncology (ESMO)
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancers (Colon, Rectum, Stomach)
- Genitourinary Cancers (Kidney, Bladder, Prostate)
- Head & Neck Cancers
- Gynaecological Cancers
- Leptomeningeal Carcinomatosis
- All types of solid tumours
- Immunotherapy
- Precision & Genomic Oncology
- Targeted Therapy
- Cancer Rehabilitation
- Administration of advanced Chemotherapy regimens
- Personalised Targeted Therapy based on molecular profiling
- Advanced Immunotherapy (Checkpoint Inhibitors)
- Management of treatment-related toxicities
- Utilisation of Cancer Genomics for treatment planning
- Associate Consultant, Medical Oncology, Sir Ganga Ram Hospital, New Delhi (Jul 2022 - Present)
- Medical Oncologist, BLK-Max Super Speciality Hospital, New Delhi (Oct 2021 - Jun 2022)
- Senior Resident (Medical Oncology), BLK-Max Super Speciality Hospital, New Delhi (Mar 2018 - Aug 2021)
- Assistant Professor (Internal Medicine), Swami Rama Himalayan University, Dehradun (Jun 2017 - Mar 2018)
- Senior Resident (Internal Medicine), Swami Rama Himalayan University, Dehradun (Jun 2016 - Jun 2017)
- Executive Member: International Oncologist Society
- Contributing Author: ISMPO (Indian Society of Medical and Paediatric Oncology) Guidelines
- Researcher: Actively involved in clinical research with publications in national and international journals.
- Honoured as an Executive Member of the International Oncologist Society, recognising his contributions to the global oncology community.
- Co-authored the ISMPO guidelines for the management of early-stage breast cancer, helping standardise care across India.
- Recognised for his expertise in the holistic management of patients, including cancer rehabilitation.
- Recipient of the prestigious ‘Young Oncologist of the Year’ award at the Times Health Conclave & Awards 2024.
- Parikh, Purvish M., et al. Management of Metastatic Colorectal Cancer (mCRC): Real-World Recommendations. South Asian Journal of Cancer. (2024).
- Singh, Randeep, Aditya Sarin, et al. ISMPO Guidelines for Diagnosis and Management of Early Breast Cancer. Indian Journal of Medical and Paediatric Oncology. (2024).
- Agarwal, Amit, Aditya Sarin, et al. Antibody Responses to SARS-CoV-2 Infection in Cancer Patients. (2021).
- Hasthavaram, Navaneeth Reddy, Aditya Sarin, et al. Diagnosing primary malignancy in leptomeningeal carcinomatosis by using CSF cytology and immunohistochemistry: A case report. Indian Journal of Medical and Paediatric Oncology. (2020).
Treatment Modality | Estimated Cost per Cycle (INR) | Estimated Cost per Cycle (USD) |
Standard Chemotherapy | ₹30,000 - ₹1,00,000 | $360 - $1,200 |
Targeted Therapy | ₹1,50,000 - ₹4,00,000+ | $1,800 - $4,800+ |
Immunotherapy | ₹1,80,000 - ₹5,00,000+ | $2,150 - $6,000+ |
Genomic Profiling Test | ₹50,000 - ₹2,50,000 (One-time) | $600 - $3,000 (One-time) |
- Language Support: Professional interpreters for seamless communication.
- Visa & Travel Assistance: Support with visa invitation letters, flight bookings, and local travel arrangements.
- Accommodation: Assistance with booking comfortable and convenient accommodation.
- Pre-treatment Virtual Consultations: We facilitate online video consultations with Dr. Sarin to discuss medical reports and formulate a preliminary treatment plan before you travel.